AP1- and NF-κB-binding sites conserved among mammalian WNT10B orthologs elucidate the TNFα-WNT10B signaling loop implicated in carcinogenesis and adipogenesis

International Journal of Molecular Medicine

Volumn 19, Issue 4, 2007, Pages 699-703

  Katoh, Masuko ^a   Katoh, Masaru ^b  

^a M&M Medical BioInformatics   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Cytokine; Diabetes mellitus; Helicobacter pylori; Hepatocellular carcinoma; Integrome network; Systems medicine; Tumor necrosis factor ; WNT

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WNT PROTEIN; WNT10B PROTEIN, HUMAN;

ADIPOGENESIS; AMINO ACID SEQUENCE; ANIMAL; ARTICLE; BINDING SITE; CATTLE; CELL TRANSFORMATION; CHEMISTRY; COMPARATIVE STUDY; GENETICS; GENOMICS; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; PAN TROGLODYTES; RAT; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION SITE;

ADIPOGENESIS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; CATTLE; CELL TRANSFORMATION, NEOPLASTIC; CONSERVED SEQUENCE; GENOMICS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PAN TROGLODYTES; PROTO-ONCOGENE PROTEINS; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION INITIATION SITE; TUMOR NECROSIS FACTOR-ALPHA; WNT PROTEINS;

EID: 34247895504     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.19.4.699     Document Type: Article

References (46)

1. Katoh M: WNT and FGF gene clusters. Int J Oncol 21: 1269-1273, 2002.
2. Katoh M: Regulation of WNT signaling molecules by retinoic acid during neuronal differentiation in NT2 cells: threshold model of WNT action. Int J Mol Med 10: 683-687, 2002.
3. Heller RS, Klein T, Ling Z, Heimberg H, Katoh M, Madsen OD and Serup P: Expression of WNT, Frizzled, sFRP, and DKK genes in adult human pancreas. Gene Expr 11: 141-147, 2003. (Pubitemid 37516647)
4. Garciadiego-Cazares D, Rosales C, Katoh M and Chimal-Monroy J: Coordination of chondrocyte differentiation and joint formation by α5β1 integrin in the developing appendicular skeleton. Development 131: 4735-4742, 2004. (Pubitemid 39433460)
5. Clevers H: Stem cells, asymmetric division and cancer. Nat Genet 37: 1027-1028, 2005. (Pubitemid 41486650)
6. Katoh M and Katoh M: Bioinformatics for cancer management in the post-genome era. Technol Cancer Res Treat 5: 169-176, 2006.
7. Katoh M and Katoh M: Cross-talk of WNT and FGF signaling pathways at GSK3β to regulate β-catenin and SNAIL signaling cascades. Cancer Biol Ther 5: 1059-1064, 2006. (Pubitemid 44772212)
8. Swain RK, Katoh M, Medina A and Steinbeisser H: Xenopus frizzled-4S, a splicing variant of Xfz4, is a context-dependent activator and inhibitor of Wnt/β-catenin signaling. Cell Commun Signal 3: 12, 2005.
9. Katoh M: WNT2B: comparative integromics and clinical application. Int J Mol Med 16: 1103-1108, 2005.
10. Katoh M: Epithelial-mesenchymal transition in gastric cancer. Int J Oncol 27: 1677-1683, 2005.
11. Katoh M and Katoh M: STAT3-induced WNT5A signaling loop in embryonic stem cells, adult normal tissues, chronic persistent inflammation, rheumatoid arthritis, and cancer. Int J Mol Med 19: 273-278, 2007.
12. Katoh M and Katoh M: Identification and characterization of human BCL9L gene and mouse Bcl9l gene in silico. Int J Mol Med 12: 643-649, 2003.
13. Chamorro MN, Schwartz DR, Vonica A, et al: FGF20 and DKK1 are transcriptional target of β-catenin and FGF20 is implicated in cancer and development. EMBO J 24: 73-84, 2005.
14. Katoh M and Katoh M: Comparative genomics on FGF20 orthologs. Oncol Rep 14: 287-290, 2005.
15. Katoh Y and Katoh M: Comparative genomics on DKK1 orthologs. Int J Oncol 27: 275-279, 2005.
16. Katoh M and Katoh M: Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells. Int J Mol Med 17: 681-685, 2006.
17. Katoh M: WNT/PCP signaling pathway and human cancer. Oncol Rep 14: 1583-1588, 2005.
18. Boutros M, Paricio N, Strutt DI, et al: Dishevelled activates JNK and discriminates between JNK pathways in planar polarity and wingless signaling. Cell 94: 109-118, 1998.
19. 2+- induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase Ia signaling in human mammary epithelial cells. Mol Cell Biol 26: 6024-6036, 2006.
20. Saitoh T, Kirikoshi H, Mine T and Katoh M: Proto-oncogene WNT10B is upregulated by tumor necrosis factor α in human gastric cancer cell line MKN45. Int J Oncol 19: 1187-1192, 2001.
21. Hardiman G, Kastelein RA and Bazan JF: Isolation, characterization and chromosomal localization of human WNT10B. Cytogenet Cell Genet 77: 278-282, 1997. (Pubitemid 27370949)
22. Katoh Y and Katoh M: Identification and characterization of rat Wnt1 and Wnt10b genes in silico. Int J Oncol 26: 841-845, 2005.
23. Bui TD, Rankin J, Smith K, et al: A novel human Wnt gene, WNT10B, maps to 12q13 and is expressed in human breast carcinomas. Oncogene 14: 1249-1253, 1997. (Pubitemid 27141929)
24. Kirikoshi H and Katoh M: Expression and regulation of WNT10B in human cancer: upregulation of WNT10B in MCF-7 cells by β-estradiol and downregulation of WNT10B in NT2 cells by retinoic acid. Int J Mol Med 10: 507-511, 2002.
25. Lee FS, Lane TF, Kuo A, et al: Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice. Proc Natl Acad Sci USA 92: 2268-2272, 1995.
26. Ross SE, Hemati N, Longo KA, et al: Inhibition of adipogenesis by Wnt signaling. Science 289: 950-953, 2000.
27. Christodoulides C, Scarda A, Granzotto M, et al: WNT10B mutations in human obesity. Diabetologia 49: 678-684, 2006.
28. Karin M: Nuclear factor-κB in cancer development and progression. Nature 441: 431-436, 2006.
29. Katoh M: Paradigm shift in gene-finding method: from bench-top approach to desk-top approach. Int J Mol Med 10: 677-682, 2002.
30. Katoh M and Katoh M: Identification and characterization of human PRICKLE1 and PRICKLE2 genes as well as mouse Prickle1 and Prickle2 genes homologous to Drosophila tissue polarity gene prickle. Int J Mol Med 11: 249-256, 2003.
31. Katoh M and Katoh M: Identification and characterization of human DAPPER1 and DAPPER2 genes in silico. Int J Oncol 22: 907-913, 2003.
32. Katoh M and Katoh M: Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico. Int J Oncol 22: 1161-1168, 2003.
33. Katoh M and Katoh M: Identification and characterization of human HES2, HES3, and HES5 genes in silico. Int J Oncol 25: 529-534, 2004.
34. Katoh M and Katoh M: Identification and characterization of human HESL, rat Hesl and rainbow trout hesl genes in silico. Int J Mol Med 14: 747-751, 2005.
35. Katoh M: Molecular evolution of WNT2B orthologs. Int J Oncol 26: 1135-1139, 2005.
36. Katoh Y and Katoh M: WNT antagonist, SFRP1, is Hedgehog signaling target. Int J Mol Med 17: 171-175, 2006.
37. Katoh Y and Katoh M: FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of WNT signaling pathway in progenitor cells. Int J Mol Med 17: 529-532, 2006.
38. Katoh M and Katoh M: CER1 is a common target of WNT and NODAL signaling pathways in human embryonic stem cells. Int J Mol Med 17: 795-799, 2006.
39. Katoh M and Katoh M: WNT antagonist, DKK2, is a Notch signaling target in intestinal stem cells: augmentation of negative regulation system for canonical WNT signaling pathway by Notch-DKK2 signaling loop in primates. Int J Mol Med 19: 197-201, 2007.
40. Katoh Y and Katoh M: Conserved POU-binding site linked to SP1-binding site within FZD5 promoter: transcriptional mechanisms of FZD5 in undifferentiated human ES cells, fetal liver/spleen, adult colon, pancreatic islet, and diffuse-type gastric cancer. Int J Oncol 30: 751-755, 2007.
41. Katoh M and Katoh M: Comparative integromics on FZD7 orthologs: conserved binding sites for PU.1, SP1, CCAAT-box and TCF/LEF/SOX transcription factors within 5′-promoter region of mammalian FZD7 orthologs. Int J Mol Med 19: 529-533, 2007.
42. Marshall BJ and Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315, 1984.
43. Katoh Y and Katoh M: Hedgehog signaling in gastric cancer. Cancer Biol Ther 4: 1050-1054, 2005.
44. Peek RM Jr and Crabtree JE: Helicobacter pylori infection and gastric neoplasia. J Pathol 208: 233-248, 2006. (Pubitemid 43126116)
45. Katoh M and Katoh M: FGF signaling network in the gastrointestinal tract. Int J Oncol 29: 163-168, 2006.
46. Crabtree JE, Shallcross TM, Heatley RV and Wyatt JI: Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32: 1473-1477, 1991.